UBS Group AG - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,134,990
-55.7%
70,760
-36.0%
0.00%
-100.0%
Q2 2023$2,562,340
+44.0%
110,541
+44.3%
0.00%0.0%
Q1 2023$1,779,162
-33.4%
76,589
-58.4%
0.00%0.0%
Q4 2022$2,670,609
+302.2%
184,053
+429.3%
0.00%
Q3 2022$664,000
-3.8%
34,772
-8.4%
0.00%
Q2 2022$690,000
-80.6%
37,962
-73.0%
0.00%
-100.0%
Q1 2022$3,549,000
-29.3%
140,839
-22.5%
0.00%0.0%
Q4 2021$5,018,000
+55.8%
181,790
+82.2%
0.00%0.0%
Q3 2021$3,221,000
+812.5%
99,749
+764.8%
0.00%
Q2 2021$353,000
-89.2%
11,535
-89.3%
0.00%
-100.0%
Q1 2021$3,274,000
+89.8%
107,524
+23.3%
0.00%0.0%
Q4 2020$1,725,000
+902.9%
87,202
+560.4%
0.00%
Q3 2020$172,000
+77.3%
13,205
+54.8%
0.00%
Q2 2020$97,000
-80.7%
8,530
-75.8%
0.00%
Q1 2020$503,000
-72.8%
35,191
-48.3%
0.00%
-100.0%
Q4 2019$1,852,000
-63.7%
68,006
-61.9%
0.00%
-50.0%
Q3 2019$5,106,000
+842.1%
178,342
+814.1%
0.00%
Q2 2019$542,000
-11.9%
19,510
+5.4%
0.00%
Q1 2019$615,000
-88.9%
18,512
-90.3%
0.00%
-100.0%
Q4 2018$5,528,000
+529.6%
190,161
+896.5%
0.00%
Q3 2018$878,000
+9.1%
19,082
-11.5%
0.00%
Q2 2018$805,000
-81.4%
21,559
-85.3%
0.00%
-100.0%
Q1 2018$4,324,000
+214.0%
146,336
+265.1%
0.00%
+100.0%
Q4 2017$1,377,000
+1.2%
40,078
+6.6%
0.00%0.0%
Q3 2017$1,360,000
-7.9%
37,605
-34.2%
0.00%0.0%
Q2 2017$1,477,000
-37.9%
57,137
-53.9%
0.00%0.0%
Q1 2017$2,380,000
-9.1%
123,980
-21.0%
0.00%0.0%
Q4 2016$2,617,000
+18.8%
156,930
+46.7%
0.00%0.0%
Q3 2016$2,202,000
-25.3%
106,969
+11.1%
0.00%
-50.0%
Q2 2016$2,946,000
+273.9%
96,254
+357.4%
0.00%
+100.0%
Q1 2016$788,000
-48.6%
21,046
-40.7%
0.00%0.0%
Q4 2015$1,533,000
-54.2%
35,513
-60.2%
0.00%
-50.0%
Q3 2015$3,345,000
+17.9%
89,239
+6.9%
0.00%0.0%
Q2 2015$2,838,000
+85.4%
83,497
+93.2%
0.00%
+100.0%
Q1 2015$1,531,000
-46.9%
43,223
-48.9%
0.00%
-50.0%
Q4 2014$2,881,00084,6140.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders